249 related articles for article (PubMed ID: 10626115)
1. Disorders of hyperpigmentation.
Pandya AG; Guevara IL
Dermatol Clin; 2000 Jan; 18(1):91-8, ix. PubMed ID: 10626115
[TBL] [Abstract][Full Text] [Related]
2. Optimal management of recalcitrant disorders of hyperpigmentation in dark-skinned patients.
Stratigos AJ; Katsambas AD
Am J Clin Dermatol; 2004; 5(3):161-8. PubMed ID: 15186195
[TBL] [Abstract][Full Text] [Related]
3. What's new in objective assessment and treatment of facial hyperpigmentation?
Molinar VE; Taylor SC; Pandya AG
Dermatol Clin; 2014 Apr; 32(2):123-35. PubMed ID: 24679999
[TBL] [Abstract][Full Text] [Related]
4. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
6. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
Rivas S; Pandya AG
Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
[TBL] [Abstract][Full Text] [Related]
7. Facial melanoses: Indian perspective.
Khanna N; Rasool S
Indian J Dermatol Venereol Leprol; 2011; 77(5):552-63; quiz 564. PubMed ID: 21860153
[TBL] [Abstract][Full Text] [Related]
8. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
9. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
[TBL] [Abstract][Full Text] [Related]
10. Periorbital hyperpigmentation and erythema dyschromicum perstans.
Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
[TBL] [Abstract][Full Text] [Related]
11. Management of hyperpigmentation in darker racial ethnic groups.
Grimes PE
Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
[TBL] [Abstract][Full Text] [Related]
12. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.
Wang RF; Ko D; Friedman BJ; Lim HW; Mohammad TF
J Am Acad Dermatol; 2023 Feb; 88(2):271-288. PubMed ID: 35151757
[TBL] [Abstract][Full Text] [Related]
13. Management of facial hyperpigmentation.
Pérez-Bernal A; Muñoz-Pérez MA; Camacho F
Am J Clin Dermatol; 2000; 1(5):261-8. PubMed ID: 11702317
[TBL] [Abstract][Full Text] [Related]
14. Established treatments of skin hypermelanoses.
Nikolaou V; Stratigos AJ; Katsambas AD
J Cosmet Dermatol; 2006 Dec; 5(4):303-8. PubMed ID: 17716250
[TBL] [Abstract][Full Text] [Related]
15. Acquired dermal macular hyperpigmentation: an overview of the recent updates.
Shah S; Baskaran N; Vinay K; Bishnoi A; Parsad D; Kumaran MS
Int J Dermatol; 2023 Dec; 62(12):1447-1457. PubMed ID: 37767951
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark-Skinned Patients: A Comparative Study.
Sarkar R; Parmar NV; Kapoor S
Dermatol Surg; 2017 Apr; 43(4):566-573. PubMed ID: 28114204
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
[TBL] [Abstract][Full Text] [Related]
18. Erythema dyschromicum perstans.
Tlougan BE; Gonzalez ME; Mandal RV; Kundu RV; Skopicki D
Dermatol Online J; 2010 Nov; 16(11):17. PubMed ID: 21163168
[TBL] [Abstract][Full Text] [Related]
19. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
Sofen B; Prado G; Emer J
Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
